Medtronic plc had one failed trial in below-the-knee peripheral arterial disease (PAD) with a previous drug-coated balloon (DCB) technology. Now, the Dublin, Ireland-based med-tech giant is giving it another shot with a small, European study using improved technology and clinical trial design. Read More
